Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Splinting in Tetraplegia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04523636
Recruitment Status : Completed
First Posted : August 21, 2020
Last Update Posted : August 21, 2020
Sponsor:
Collaborators:
University of Maryland, Baltimore
The Craig H. Neilsen Foundation
Information provided by (Responsible Party):
Thomas Jefferson University

Brief Summary:
This study compared pre-fabricated and custom resting hand splints among people who were in inpatient rehabilitation after a cervical spinal cord injury.

Condition or disease Intervention/treatment Phase
Spinal Cord Injury Cervical Splints Device: Splinting Not Applicable

Detailed Description:
This was randomized parallel group controlled clinical trial where arms, not patients were the unit of randomization. This trial was funded by the Craig H. Neilsen Allied Health Professional Development Award of the American Spinal Injury Association (ASIA). This research was conducted at a 32-bed spinal cord injury and multi-trauma rehabilitation unit in an urban center. Participants were recruited from an inpatient spinal cord injury rehabilitation unit. Eligible participants were 18 years or older and undergoing acute rehabilitation after a cervical spinal cord injury with hand function impairment, and the primary occupational therapist deemed splinting intervention was required. Each eligible extremity was randomized to receive a custom or pre-fabricated resting hand splint for night use.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 36 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Each extremity was randomized to receive a custom or pre-fabricated resting hand splint.
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evaluation of Splinting in Tetraplegia
Actual Study Start Date : January 4, 2018
Actual Primary Completion Date : December 20, 2018
Actual Study Completion Date : December 20, 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Custom Splint
Custom Splint- Thermoplastic device fabricated by occupational therapist
Device: Splinting
Pre-fabricated or custom resting hand splints

Active Comparator: Prefabricated Splint
Prefabricated Splint- Commercially available from Restorative Care of America, Inc (RCAI)
Device: Splinting
Pre-fabricated or custom resting hand splints




Primary Outcome Measures :
  1. Change in scores on The Graded Redefined Assessment of Strength, Sensation and Prehension (GRASSP). [ Time Frame: This assessment is completed within 5 days of initating the splinting intervention and within 3 days of discharge. Length of time between data collection was limited to 12 weeks. ]

    This test is a hand function assessment for spinal cord injury consisting of four domains- upper extremity strength, sensation, qualitative prehension, and quantitative prehension. Total scores for each upper extremity are calculated 0-116. Assessment of the Hand in Tetraplegia Using the Graded Redefined Assessment of Strength Sensibility and Prehension (GRASSP): Impairment versus Function.

    Kalsi-Ryan S, Curt A, Fehlings, MG and Verrier MC. Top Spinal Cord Inj Rehabil (2009); 14(4):34-46. - C



Secondary Outcome Measures :
  1. Splint Perception Survey [ Time Frame: This assessment was completed within 3 days of discharge and no more than 12 weeks after the intervention was initiated. ]
    This survey gathered participant perceptions via a 5 point Likert scale on the participant's perceptions of the splint's comfort and impact on function and hand position. Additionally, participants were asked to provide their perceptions on challenges to using the splint and advice to future therapists and patients considering splinting.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Spinal Cord Injury
  • Inpatient Rehabilitation
  • Limited hand function

Exclusion Criteria:

  • Under 18
  • Full hand function
  • Orthopedic injury to hand

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04523636


Locations
Layout table for location information
United States, Maryland
University of MD Rehabilitation & Orthopaedic Institute
Baltimore, Maryland, United States, 21207
United States, Pennsylvania
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107
Sponsors and Collaborators
Thomas Jefferson University
University of Maryland, Baltimore
The Craig H. Neilsen Foundation
Investigators
Layout table for investigator information
Principal Investigator: Peter Gorman, MD University of Maryland, Baltimore
Principal Investigator: Paula Geigle, PhD University of Maryland, Baltimore
Study Director: Sara Frye, MS Thomas Jefferson University
Layout table for additonal information
Responsible Party: Thomas Jefferson University
ClinicalTrials.gov Identifier: NCT04523636    
Other Study ID Numbers: HP-00075158
First Posted: August 21, 2020    Key Record Dates
Last Update Posted: August 21, 2020
Last Verified: August 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Spinal Cord Injuries
Quadriplegia
Spinal Cord Diseases
Central Nervous System Diseases
Nervous System Diseases
Trauma, Nervous System
Wounds and Injuries
Paralysis
Neurologic Manifestations